Yoon Esther Y, Cohn Lisa, Freed Gary, Rocchini Albert, Kershaw David, Ascione Frank, Clark Sarah
Division of General Pediatrics, Child Health Evaluation and Research (CHEAR) Unit, University of Michigan, Ann Arbor, Michigan.
Division of General Pediatrics, Child Health Evaluation and Research (CHEAR) Unit, University of Michigan, Ann Arbor, Michigan.
J Adolesc Health. 2014 Jul;55(1):73-8. doi: 10.1016/j.jadohealth.2013.12.006. Epub 2014 Feb 1.
To compare the use of antihypertensive medications and diagnostic tests among adolescents and young adults with primary versus secondary hypertension.
We conducted retrospective cohort analysis of claims data for adolescents and young adults (12-21 years of age) with ≥3 years of insurance coverage (≥11 months/year) in a large private managed care plan during 2003-2009 with diagnosis of primary hypertension or secondary hypertension. We examined their use of antihypertensive medications and identified demographic characteristics and the presence of obesity-related comorbidities. For the subset receiving antihypertensive medications, we examined their diagnostic test use (echocardiograms, renal ultrasounds, and electrocardiograms).
The study sample included 1,232 adolescents and young adults; 84% had primary hypertension and 16% had secondary hypertension. The overall prevalence rate of hypertension was 2.6%. One quarter (28%) with primary hypertension had one or more antihypertensive medications, whereas 65% with secondary hypertension had one or more antihypertensive medications. Leading prescribers of antihypertensives for subjects with primary hypertension were primary care physicians (80%), whereas antihypertensive medications were equally prescribed by primary care physicians (43%) and sub-specialists (37%) for subjects with secondary hypertension.
The predominant hypertension diagnosis among adolescents and young adults is primary hypertension. Antihypertensive medication use was higher among those with secondary hypertension compared with those with primary hypertension. Further study is needed to determine treatment effectiveness and patient outcomes associated with differential treatment patterns used for adolescents and young adults with primary versus secondary hypertension.
比较原发性高血压与继发性高血压的青少年和青年成人使用降压药物及诊断检查的情况。
我们对2003年至2009年期间在一家大型私立管理式医疗计划中,有≥3年保险覆盖(≥11个月/年)且诊断为原发性高血压或继发性高血压的12至21岁青少年和青年成人的理赔数据进行了回顾性队列分析。我们检查了他们降压药物的使用情况,并确定了人口统计学特征以及肥胖相关合并症的存在情况。对于接受降压药物治疗的亚组,我们检查了他们的诊断检查使用情况(超声心动图、肾脏超声和心电图)。
研究样本包括1232名青少年和青年成人;84%患有原发性高血压,16%患有继发性高血压。高血压的总体患病率为2.6%。四分之一(28%)的原发性高血压患者使用了一种或多种降压药物,而65%的继发性高血压患者使用了一种或多种降压药物。原发性高血压患者降压药物的主要开方者是初级保健医生(80%),而继发性高血压患者的降压药物由初级保健医生(43%)和专科医生(37%)开方的比例相同。
青少年和青年成人中主要的高血压诊断类型是原发性高血压。与原发性高血压患者相比,继发性高血压患者的降压药物使用更高。需要进一步研究以确定与原发性和继发性高血压的青少年和青年成人不同治疗模式相关的治疗效果和患者预后。